Private hospital merger to be approved if local concerns addressed
The CMA has found that the completed private hospital merger between Circle and BMI does not raise UK-wide competition concerns but could reduce competition...
NICE COVID-19 guidelines: severe asthma, pneumonia, rheumatological disorders, symptom management
New NICE COVID-19 guidelines have been published on severe asthma, pneumonia, rheumatological disorders and symptom management in community settings. NICE has published the four new...
Rapid COVID-19 diagnostic test to be deployed in hospitals
A new rapid COVID-19 diagnostic test developed by a University of Cambridge spinout company and capable of diagnosing the infection in under 90 minutes,...
More NICE rapid COVID-19 guidelines published
NICE has published its second set of rapid COVID-19 guidelines which cover the provision of radiotherapy services and bone marrow transplant during the COVID-19...
Low dose of aspirin no help for dementia
Researchers in Australia have found no evidence that in low doses, aspirin reduces the risk of dementia or slows a decline in memory and...
UK to map coronavirus spread with whole genome sequence alliance
The UK is to map coronavirus spread with the launch of a whole genome sequence alliance.
The Government and the UK’s Chief Scientific Adviser have...
NICE guidelines on active management of patients with COVID-19
The National Institute for Health and Care Excellence (NICE) has published its first three rapid guidelines on the active management of patients with COVID-19...
The hidden costs of heart failure on the NHS
The first investigation of its kind, published in Open Heart, has identified the hidden costs of heart failure (HF) due to under-managed but treatable...
NICE’s new Chief Executive announced
Professor Gillian Leng, CBE, has been appointed as NICE's new Chief Executive. Gillian has held the post of Deputy Chief Executive at the National Institute...
HIV drug PrEP made available across England
The Department of Health and Social Care has announced that HIV drug PrEP is to be made available across England. Local authorities will receive...
Latest articles
NICE recommends ADCETRIS▼ (brentuximab vedotin), in combination with chemotherapy, as frontline treatment for a...
Takeda UK has announced that the National Institute for Health and Care Excellence (NICE) has recommended ADCETRIS (brentuximab vedotin) with cyclophosphamide, doxorubicin and prednisone...
CMA formally concludes fludrocortisone investigation
The Competition and Markets Authority (CMA) has formally concluded its fludrocortison investigation and found that three pharmaceutical companies took part in an illegal arrangement...
MHRA response to Independent Medicines and Medical Devices Safety Review
The Medicines and Healthcare products Regulatory Agency (MHRA) has published its response to the Independent Medicines and Medical Devices Safety Review. In its response, the...
Popular articles
New Normal, New Thinking: Life Post COVID-19
New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
The ABPI Code & Virtual Promotional Meetings
As the pharma industry looks to virtual meetings and teams work remotely, what considerations are there around the ABPI Code and virtual promotional meetings? Whilst...
First Do No Harm: Independent Medicines and Medical Devices Safety Review publishes its recommendations
The Independent Medicines and Medical Devices Safety Review, chaired by Baroness Julia Cumberlege, has today published its report. Titled 'First Do No Harm', it comes...
Study shows anti-parasitic drug ivermectin kills coronavirus within 48 hours
A collaborative study led by the Monash Biomedicine Discovery Institute (BDI) with the Peter Doherty Institute of Infection and Immunity (Doherty Institute), a joint...
NICE recommends ADCETRIS▼ (brentuximab vedotin), in combination with chemotherapy, as frontline treatment for a...
Takeda UK has announced that the National Institute for Health and Care Excellence (NICE) has recommended ADCETRIS (brentuximab vedotin) with cyclophosphamide, doxorubicin and prednisone...